2004
DOI: 10.1002/chin.200413093
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Antibacterial Activity of Pyrroloaryl‐Substituted Oxazolidinones.

Abstract: Synthesis and Antibacterial Activity of Pyrroloaryl-Substituted Oxazolidinones. -A series of pyrroloaryl-substituted oxazolidinones are prepared and screened against a panel of susceptible and resistant Gram-positive bacteria. (VII), (XI) and (XII) show superior or comparable in vitro antibacterial activity as compared to linezolid. -(PAGET*, S. D.; FOLENO, B. D.; BOGGS, C. M.; GOLDSCHMIDT, R. M.; HLASTA, D. J.; WEIDNER-WELLS, M. A.; WERBLOOD, H. M.; WIRA, E.; BUSH, K.; MACIELAG, M. J.; Bioorg. Med. Chem. Lett… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(15 citation statements)
references
References 1 publication
0
15
0
Order By: Relevance
“…8 General experimental procedure for the synthesis of 7a-f 4-Chloro-2-(cyclohexylmethyl)-3-(morpholinomethyl)-1H-pyrrolo[3,2-c]pyridine (7d) as an example: In an oven-dried RB flask, compound 6c (250 mg, 1.01 mmol) and formaldehyde solution, 37-41 wt.% in water (0.15 mL, 2.02 mmol) were mixed in glacial acetic acid (5 mL). Morpholine (220.4 mg, 2.53 mmol) was added drop wise at 0°C.…”
Section: Methodsmentioning
confidence: 97%
See 2 more Smart Citations
“…8 General experimental procedure for the synthesis of 7a-f 4-Chloro-2-(cyclohexylmethyl)-3-(morpholinomethyl)-1H-pyrrolo[3,2-c]pyridine (7d) as an example: In an oven-dried RB flask, compound 6c (250 mg, 1.01 mmol) and formaldehyde solution, 37-41 wt.% in water (0.15 mL, 2.02 mmol) were mixed in glacial acetic acid (5 mL). Morpholine (220.4 mg, 2.53 mmol) was added drop wise at 0°C.…”
Section: Methodsmentioning
confidence: 97%
“…Other examples include the synthetic pyrrolopyridine derivative diazarebeccamycin 2 is a potent anticancer agent [2], pyrrolo [2,3-c]pyridine 3 which has demonstrated activity as an inhibitor of HIV-1 attachment to CD4 + T cells [3] and pyrrolo [2,3-b]pyridine 4 is a potent p38 kinase inhibitor [4]. Pyrrolopyridines also posses significant biological applications such as antimicrobial [5][6][7][8][9], analgesic [10], antimalarial [11], antiproliferative [12], antihypertensive [13], cannabinoid activity [14,15] and Factor VIIa inhibitors [16]. As a result of our considerable interest in the synthesis of pyridine-containing compounds and their antimicrobial activity [17], we initiated a programme directed towards the synthesis of new pyrrolopyridine compounds.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In another recent study using the pyrrolo[3,4-b]pyridinyl oxazolidinone core structure as the template, compounds 74 and 75 were found to exhibit 2 to 4-fold better antibacterial activities than Linezolid [81]. Various modifications of the C-5 acetamido group have been carried out but failed to produce a suitable isosteric replacement.…”
Section: C-5 Side Chain Modificationmentioning
confidence: 96%
“…Oxazolidinones containing a lactam substituent represented not only antibacterial agents 28,29 but also antithrombotic agents. Rivaroxaban, a lactam substituted oxazolidinone marketed as Xarelto, is orally active and highly potent coagulation factor Xa inhibitors and has been approved in United States recently for the prophylaxis of venous thromboembolism (VTE).…”
Section: 25mentioning
confidence: 99%